论文标题： BLM interaction with EZH2 regulates MDM2 expression and is a poor prognostic biomarker for prostate cancer
DOI： PMID:33948362
发表时间： 2021-04-15
期刊： American Journal of Cancer Research
影响因子： 6.166
货号： ZQ0351
产品名称： RWPE-1 cells
原文链接： https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085859/

论文标题： HepaCAM‑PIK3CA axis regulates the reprogramming of glutamine metabolism to inhibit prostate cancer cell proliferation
DOI： 10.3892/ijo.2022.5327
发表时间： 2022-02-22
期刊： INTERNATIONAL JOURNAL OF ONCOLOGY
影响因子： 5.65
货号： ZQ0351
产品名称： RWPE-1

原文链接： https://www.spandidos-publications.com/10.3892/ijo.2022.5327

论文标题： PLCε knockdown prevents serine/glycine metabolism and proliferation of prostate cancer by suppressing YAP
DOI： PMID:32064161
发表时间： 2020-01-01
期刊： American Journal of Cancer Research
影响因子： 5.177
货号： ZQ0351
产品名称： RWPE-1 cells
原文链接： https://www.ncbi.nlm.nih.gov/pmc/articles/pmc7017741/

论文标题： EGFR/FOXO3A/LXR-α Axis Promotes Prostate Cancer Proliferation and Metastasis and Dual-Targeting LXR-α/EGFR Shows Synthetic Lethality
DOI： 10.3389/fonc.2020.01688
发表时间： 2020-11-02
期刊： Frontiers in Oncology
影响因子： 4.848
货号： ZQ0351
产品名称： RWPE-1 cell line
原文链接： https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667376/

论文标题： Curcumol inhibits the malignant progression of prostate cancer and regulates the PDK1/AKT/mTOR pathway by targeting miR‑9
DOI： 10.3892/or.2021.8197
发表时间： 2021-09-28
期刊： ONCOLOGY REPORTS
影响因子： 3.906
货号： ZQ0351
产品名称： normal prostate cells (RWPE-1)
原文链接： https://www.spandidos-publications.com/10.3892/or.2021.8197

论文标题： High expression of NPM1 via the Wnt/β-catenin signalling pathway might predict poor prognosis for patients with prostate adenocarcinoma
DOI： 10.1111/1440-1681.13628
发表时间： 2022-02-14
期刊： CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
影响因子： 2.557
货号： ZQ0351
产品名称： RWPE-1 cells

原文链接： https://onlinelibrary.wiley.com/doi/abs/10.1111/1440-1681.13628

PubMed=8977636; DOI=10.1002/(SICI)1097-0045(199612)29:6<386::AID-PROS7>3.0.CO;2-6
Webber M.M., Bello D., Quader S.T.A.
Immortalized and tumorigenic adult human prostatic epithelial cell lines: characteristics and applications. Part I. Cell markers and immortalized nontumorigenic cell lines.
Prostate 29:386-394(1996)

PubMed=9214605; DOI=10.1093/carcin/18.6.1215
Bello D., Webber M.M., Kleinman H.K., Wartinger D.D., Rhim J.S.
Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18.
Carcinogenesis 18:1215-1223(1997)

PubMed=9214606; DOI=10.1093/carcin/18.6.1225
Webber M.M., Bello D., Kleinman H.K., Hoffman M.P.
Acinar differentiation by non-malignant immortalized human prostatic epithelial cells and its loss by malignant cells.
Carcinogenesis 18:1225-1231(1997)

Patent=US6255058
Webber M.M., Rhim J.S.
Immortalized and malignant human prostatic cell lines.
Patent number US6255058, 03-Jul-2001

PubMed=20215515; DOI=10.1158/0008-5472.CAN-09-3458
Rothenberg S.M., Mohapatra G., Rivera M.N., Winokur D., Greninger P., Nitta M., Sadow P.M., Sooriyakumar G., Brannigan B.W., Ulman M.J., Perera R.M., Wang R., Tam A., Ma X.-J., Erlander M., Sgroi D.C., Rocco J.W., Lingen M.W., Cohen E.E.W., Louis D.N., Settleman J., Haber D.A.
A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers.
Cancer Res. 70:2158-2164(2010)

PubMed=22275356; DOI=10.1074/jbc.M111.302547
Lynch T.P., Ferrer C.M., Jackson S.R., Shahriari K.S., Vosseller K., Reginato M.J.
Critical role of O-linked beta-N-acetylglucosamine transferase in prostate cancer invasion, angiogenesis, and metastasis.
J. Biol. Chem. 287:11070-11081(2012)

PubMed=25877200; DOI=10.1038/nature14397
Yu M., Selvaraj S.K., Liang-Chu M.M.Y., Aghajani S., Busse M., Yuan J., Lee G., Peale F.V., Klijn C., Bourgon R., Kaminker J.S., Neve R.M.
A resource for cell line authentication, annotation and quality control.
Nature 520:307-311(2015)

PubMed=27397505; DOI=10.1016/j.cell.2016.06.017
Iorio F., Knijnenburg T.A., Vis D.J., Bignell G.R., Menden M.P., Schubert M., Aben N., Goncalves E., Barthorpe S., Lightfoot H., Cokelaer T., Greninger P., van Dyk E., Chang H., de Silva H., Heyn H., Deng X.-M., Egan R.K., Liu Q.-S., Mironenko T., Mitropoulos X., Richardson L., Wang J.-H., Zhang T.-H., Moran S., Sayols S., Soleimani M., Tamborero D., Lopez-Bigas N., Ross-Macdonald P., Esteller M., Gray N.S., Haber D.A., Stratton M.R., Benes C.H., Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.
A landscape of pharmacogenomic interactions in cancer.
Cell 166:740-754(2016)

PubMed=30305041; DOI=10.1186/s12885-018-4848-x
Jividen K., Kedzierska K.Z., Yang C.-S., Szlachta K., Ratan A., Paschal B.M.
Genomic analysis of DNA repair genes and androgen signaling in prostate cancer.
BMC Cancer 18:960.1-960.20(2018)

PubMed=30787054; DOI=10.1158/1055-9965.EPI-18-1132
Hooker S.E. Jr., Woods-Burnham L., Bathina M., Lloyd S., Gorjala P., Mitra R., Nonn L., Kimbro K.S., Kittles R.A.
Genetic ancestry analysis reveals misclassification of commonly used cancer cell lines.
Cancer Epidemiol. Biomarkers Prev. 28:1003-1009(2019)